Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

February 23, 2021

Entering a new era of quantifying glutamate clearance in health and disease.

Journal of Neuroscience Research
Kyle J BrymerMatthew P Parsons
February 3, 2021

Astrocyte Mitochondria in White-Matter Injury.

Neurochemical Research
Hung NguyenSelva Baltan
January 19, 2021
Open Access

SEMA4D upregulation signals neuronal stress and triggers reactive transformation of astrocytes

Maurice ZaudererElizabeth Evans
January 6, 2021
Open Access

Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington's disease patients.

NeuroImage. Clinical
Marjolein BulkLouise van der Weerd
December 5, 2020

Huntingtin Levels are Elevated in Hippocampal Post-Mortem Samples of Alzheimer's Disease Brain.

Current Alzheimer Research
Michael AxenhusSophia Schedin-Weiss
November 23, 2020
Open Access

SREBP2 delivery to striatal astrocytes normalizes transcription of cholesterol biosynthesis genes and ameliorates pathological features in Huntington's disease

BioRxiv : the Preprint Server for Biology
G. BiroliniMarta Valenza
November 13, 2020
Open Access

Morphine produces better thermal analgesia in young Huntington mice and are associated with less neuroinflammation in spinal cord

Journal of the Chinese Medical Association : JCMA
Yuan-Yuarn LiuYen-Chin Liu
November 4, 2020

Quantitative neurotoxicology: Potential role of artificial intelligence/deep learning approach

Journal of Applied Toxicology : JAT
Anshul Srivastava, Joseph P Hanig
October 30, 2020
Open Access

24S-hydroxycholesterol: cellular effects and variations in brain diseases

Journal of Neurochemistry
Alejandro O Sodero
October 3, 2020

Biological evidence of gintonin efficacy in memory disorders.

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Md JakariaDong-Kug Choi
September 26, 2020

White matter and neurological disorders

Archives of Pharmacal Research
Han-Gyu BaeDong-Gyu Jo
August 18, 2020
Open Access

Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier

European Journal of Cell Biology
Ali ShariatiAli Hassanzadeh
August 8, 2020
Open Access

The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene.

The Journal of Biological Chemistry
Jeong Su ByunBaek-Soo Han
July 28, 2020
Open Access

Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes

International Journal of Molecular Sciences
Ching-On Wong
July 15, 2020
Open Access

The role of glia in protein aggregation

Neurobiology of Disease
Qingyun Li, Michael S Haney

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved